Commentary on the new study published by the Verona CF Center on Shwachman-Diamond Syndrome
Ataluren Boosts Blood and Pancreas Health in Shwachman-Diamond
CFC Verona News
Pomeriggi di aggiornamento in Fibrosi cistica
October – December 2025
La Fibrosi cistica: rivalutazione e consolidamento della modalità di gestione del paziente con necessità di drenaggio delle secrezioni bronchiali
14 October 2025
The WHO has added CF medicines to its list of Essential Medicines
This document now lists ETI (Kaftrio), ivacaftor (Kalydeco) and pancreatic enzymes (e.g. Creon) as essential medicines.
A first therapy for Shwachman-Diamond Syndrome: Verona Cystic Fibrosis Center at the forefront of scientific research
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series.
XXI Congresso Nazionale della Società Italiana Fibrosi Cistica (SIFC)
27-29 November 2025
European Respiratory Society Congress 2025
27 September – 1 October 2025
North American Cystic Fibrosis Conference 2025
22-25 October 2025, Seattle
Meeting di Primavera 2025 della Società Italiana Fibrosi Cistica
16-17 May 2025, Verona
48th European Cystic Fibrosis Conference
4-7 June 2025, Milan